Boudreau Philip P 4
4 · ABBOTT LABORATORIES · Filed Feb 27, 2025
Insider Transaction Report
Form 4
Boudreau Philip P
EVP AND CFO
Transactions
- Award
Common shares without par value
2025-02-25+22,495→ 61,461 total - Award
Option (right to buy)
2025-02-25+83,783→ 83,783 totalExercise: $135.42From: 2026-02-25Exp: 2035-02-24→ Common Shares (83,783 underlying)
Holdings
- 360(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 25, 2025.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,927 on February 25, 2026, 27,928 on February 25, 2027, and 27,928 on February 25, 2028.